Aratana Therapeutics Stock Price (NASDAQ:PETX)

Add to My Stocks
$5.84 $0.39 (7.16%) PETX stock closing price Sep 19, 2018 (Closing)
Prev Close* : $5.45
Market Cap:
$259.81M
Day Low: $5.47
52 Week Low: $3.67
Open: $5.47
Volume: -
Day High: $5.94
52 Week High: $7.28
Dividend:
0.00

Latest Stock Market News

Latest Articles

Aratana Therapeutics News - From Partners

PETX Stockcharts

View PETX PE ratio, PS ratio stocks charts and compare with peers.
PETX Chart
Note: Compare Aratana Therapeutics stock price history with the index and industry peers.

Aratana Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
10.57
PB ratio (
price to book ratio
)
2.92

Aratana Therapeutics Returns

ROE
(return on equity)
-43%

Aratana Therapeutics Financial Ratios

Asset Turnover
0.15
Receivables Turnover
5.81
Debt to Equity
0.32
Dividend Yield
0%

PETX Industry Peers

Company Price Change (%)
Bellicum (BLCM)6.360.08 (1.27%)
Foamix (FOMX)5.560.37 (7.13%)
Nexvet Biopharma (NVET)6.720 (0%)
Oasmia Pharma (OASM)2.750.3 (9.84%)
Zoetis (ZTS)89.080.1 (0.11%)
Nexvet Biopharma (NVET)6.720 (0%)
Karyopharm Therapeutics (KPTI)18.490.08 (0.43%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Aratana Therapeutics Inc Stock News - Partner Headlines

Aratana Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues25.57M38.55M---
Net Income-47.51M-33.57M-84.05M-38.81M-4.28M
Total Operating Expense53.28M65.85M89.8M42.04M19.49M
View Aratana Therapeutics income statement
balance sheet20172016201520142013
Total Assets135.19M151.4M147.06M207.9M115.53M
Total Liabilities55.05M61M45.51M26.07M29.49M
Shareholders Equity80.13M90.4M101.55M181.83M86.04M
View Aratana Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-7.62M-0.54M-0.15M-2.7M1.83M
Net Cash from (used by) Operating Activities-38.18M-11.32M-38.49M-32.18M-16.15M
Increase (Decrease) in Prop Plant And Equipment--0.07M-2.24M-0.47M-0.09M
View Aratana Therapeutics cash flow statement

Aratana Therapeutics Stock Message Board

Aratana Therapeutics stock price ended the last trading day at $5.84. Aratana Therapeutics market capitalization is $259.81M and it represents the total market value of PETX stock. Aratana Therapeutics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Aratana Therapeutics is worth a lot, it will most likely be reflected in an inflated Aratana Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 324,082 on the last trading day, as is evident from Aratana Therapeutics stock chart, and PETX stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Aratana Therapeutics dividend per share was 0.00 during the last quarter. To check the historical stock price movement, all time high, and all time low of PETX, view Aratana Therapeutics stock price history.